New patch may stop dangerous air leaks after lung surgery

NCT ID NCT06934486

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special patch (TissuePatch SF) used during lung surgery to prevent air leaks. About 250 adults having planned lung surgery will receive the patch, and doctors will check how well it seals the lung and if it causes any side effects. The goal is to see if the patch helps patients recover more safely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing lung resection

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Is ≥18 and \<80 years of age 2. Undergoing planned (not emergent) video-assisted thoracic surgery pulmonary resection 3. Understands and is willing to comply with all study related procedures 4. Has provided signed informed consent Exclusion Criteria: 1. Women who are pregnant or lactating or, if of childbearing potential, are unwilling to use birth control for 6-months following surgery 2. Has severe congestive heart failure, pulmonary or renal failure, serious haematological disorder or significant liver disease 3. Has previously undergone a pneumonectomy 4. Has a bronchial fistula 5. Has or is suspected of having an active infection at or near the planned surgical site 6. Has a known allergy or sensitization to TissuePatch SF or its constituent components 7. In the investigator's opinion, has a life expectancy of less than 12 months 8. Has, in the investigator's opinion, any disease or condition, physical or psychological, that could interfere with the evaluation of TissuePatch SF or compliance with study procedures Intra-Operative Exclusion Criteria: 1. \>3 identified air leaks 2. No air leaks Macchiarini Grade ≥1

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-operative air leaks are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.